U.S. FDA grants priority review to Roche's : vimarsana.com

If approved, Actemra/RoActemra would be the first U.S. FDA-approved immunomodulator for the treatment of COVID-19 in hospitalised patientsSince the...

Related Keywords

Japan , Honduras , Australia , Philippines , United States , Horby , Vinnyts Ka Oblast , Ukraine , Hong Kong , United Kingdom , Bolivia , Guatemala , Canada , New Zealand , Ghana , Ecuador , Chile , Peru , Switzerland , America , Nathalie Meetz , Levi Garraway , Actemra Roactemra , Loren Kalm , Genentech , Gilead Sciences Inc , European Union , Tools Accelerator Initiative , United States Department Of Health , Biomedical Advanced Research , Human Services , Drug Administration , World Health Organization , Head Of Global Product Development , Development Authority , Clinical Trial Programme , Office Of The , Roche Group , Roche Group Media Relations , Biologics License Application , Priority Review , Chief Medical Officer , Global Product Development , Emergency Use Authorization , World Health , Assistant Secretary , United States Department , New England Journal , Gilead Sciences , Dow Jones Sustainability Indices , Chugai Pharmaceutical , Between March , Hospitalized Patients , Patients Hospitalized , Swiss Stock Exchange Ro , F Hoffmann La Roche Ltd ,